Chinese wholesale Alpha-Lipoic Acid - Tadalafil 171596-29-5 Hormone and endocrine ED treatment – Neore
Chinese wholesale Alpha-Lipoic Acid - Tadalafil 171596-29-5 Hormone and endocrine ED treatment – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 500kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods
Introduction
Tadalafil, is a medication used to treat erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension.
Specification (USP42)
Item |
Specification |
Appearance |
White or almost white powder |
Solubility |
Freely soluble in dimethyl sulfoxide, slightly soluble in methylene chloride and practically insoluble in water. |
Identification |
IR, HPLC |
Loss on drying | ≤0.5% |
Residue on ignition | ≤0.10% |
Enantiomeric and Dia-stereomeric purity By HPLC | 6R,12aS Dia-stereomer ≤0.1% |
6S,12aS Enantiomer ≤0.1% | |
6S,12aR Dia-stereomer ≤0.1% | |
Chromatographic Purity by HPLC | Individual impurity ≤0.1% |
Total impurities ≤0.3% | |
Assay by HPLC (on dried basis) | 97.5%~102.5% |
Product detail pictures:
Related Product Guide:
Bear "Customer initially, High quality first" in mind, we do the job closely with our customers and supply them with efficient and skilled providers for Chinese wholesale Alpha-Lipoic Acid - Tadalafil 171596-29-5 Hormone and endocrine ED treatment – Neore , The product will supply to all over the world, such as: Doha, Uzbekistan, Japan, Our experience makes us important in our customer eyes. Our quality speaks itself the properties like it do not tangle, shed or breakdown, so that are our customers will always be confident while placing an order.
By Monica from Philadelphia - 2018.07.27 12:26
Product quality is good, quality assurance system is complete, every link can inquire and solve the problem timely!
By Rachel from Sheffield - 2018.12.11 11:26